Abiraterone trials for Metastatic Castration-resistant Prostate Cancer

All Abiraterone trials · All Metastatic Castration-resistant Prostate Cancer trials

Phase breakdown

Recruiting trials studying Abiraterone for Metastatic Castration-resistant Prostate Cancer

• A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
  NCT06764485 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 281 locations
• A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
  NCT07287150 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 48 locations
• AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
  NCT07611110 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 132 locations
• The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
  NCT06520345 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 33 locations

Common questions

How many trials study Abiraterone for Metastatic Castration-resistant Prostate Cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.